foscarnet and thalidomide

foscarnet has been researched along with thalidomide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Avril, MF; Dallot, A; Di Lucca-Christment, J; Dupin, N; Gressier, L; Jacobelli, S; Laude, H; Morini, JP; Plantier, F; Rosenberg, F; Rozenberg, F1

Reviews

1 review(s) available for foscarnet and thalidomide

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

2 other study(ies) available for foscarnet and thalidomide

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Anogenital pseudotumoral herpes and HIV infection: a new challenge for diagnosis and treatment.
    AIDS (London, England), 2012, Feb-20, Volume: 26, Issue:4

    Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Carcinoma, Squamous Cell; Cidofovir; Condylomata Acuminata; Cytosine; Diagnosis, Differential; Female; Foscarnet; Humans; Male; Middle Aged; Organophosphonates; Papillomavirus Infections; Thalidomide; Treatment Outcome; Tumor Virus Infections

2012